David Shaw’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.8M Buy
135,600
+46,000
+51% +$9.12M 0.01% 1100
2026
Q2
$16.8M Buy
89,600
+58,400
+187% +$8.53M 0.01% 1418
2026
Q1
$3.03M Buy
+31,200
New +$3.15M ﹤0.01% 2585

Other funds holding RVMD

David Shaw's RVMD Position: Q3 2026 in Review

David Shaw sold out of Revolution Medicines (RVMD) in Q3 2026, closing a stake of 12,400 shares — an estimated $2.46M sold.

David Shaw first reported a position in RVMD in Q1 2021 and held it in 18 quarters. The position peaked at $129M in Q4 2025. 757 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • David Shaw reported no remaining Revolution Medicines position as of Q3 2026 after selling out during the quarter.
  • David Shaw sold 12,400 Revolution Medicines shares in Q3 2026, an estimated $2.46M.
  • David Shaw first reported a position in Revolution Medicines in Q1 2021 and held it in 18 quarters.
  • David Shaw's Revolution Medicines position peaked at $129M in Q4 2025.
  • 757 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.